<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
January 17, 1997
- --------------------------------------------------------------------------------
Modern Medical Modalities Corporation
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
New Jersey
- --------------------------------------------------------------------------------
(State or other jurisdiction of incorporation)
0-23416 22-3059258
- ----------------------------- -----------------------------------
(Commission File Number) (IRS Employer Identification No.)
95 Madison Avenue, Suite 301, Morristown, N.J. 07960
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code
(201) 538-9955
- --------------------------------------------------------------------------------
N/A
- --------------------------------------------------------------------------------
(Former name of former address, if changed since last report)
<PAGE>
Item 1. Changes in Control of Registrant
N/A
Item 2. Acquisition of Disposition
N/A
Item 3. Bankruptcy or Receivership
N/A
Item 4. Changes in Registrant's Certifying Accountant
(a) On January 17, 1997, the Company dismissed DDK & Company LLP, located
at 1500 Broadway - 12th Floor, New York, New York 10036. The Company has
engaged Weinick, Sanders & Co. LLP, located at 1515 Broadway, New York, New York
10036 as its new certified pubic accountants.
(b) In connection with the recent fiscal year and subsequent interim
period preceding DDK & Company LLP's, dismissal there were no disagreements with
DDK & Company LLP on any matter of accounting principals or practices, financial
statement disclosure, or auditing scope or procedure.
(c) DDK & Company LLP's report on the financial statements for either of
the past two years did not contain an adverse opinion or disclaimer of opinion
and was not qualified or modified.
(d) The Company has requested that DDK & Company LLP furnish them with a
letter addressed to the Securities and Exchange Commission (the "Commission")
stating whether they agree with the statements made by the Company in response
to this item, and if not, stating the respects in which he does not agree.
(e) The decision to change accountants was recommended and approved by the
Board of Directors.
Item 5. Other Events
N/A
Item 6. Resignation of Registrant's Directors
N/A
Item 7. Financial Statements and Exhibits
a. Financial statements of businesses acquired.
N/A
b. Pro forma financial information.
N/A
c. Exhibits.
N/A
<PAGE>
SIGNATURES
Modern Medical Modalities Corporation
-------------------------------------
(Registrant)
Date: January 17, 1997 By: /s/Jan Goldberb
-------------------------------
Jan Goldberg, Vice-President
